pirinixic acid has been researched along with Coronary Disease in 2 studies
pirinixic acid: structure
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vu-Dac, N | 1 |
| Schoonjans, K | 1 |
| Kosykh, V | 1 |
| Dallongeville, J | 1 |
| Fruchart, JC | 2 |
| Staels, B | 2 |
| Auwerx, J | 1 |
| Koenig, W | 1 |
| Habib, A | 1 |
| Merval, R | 1 |
| Lebret, M | 1 |
| Torra, IP | 1 |
| Delerive, P | 1 |
| Fadel, A | 1 |
| Chinetti, G | 1 |
| Najib, J | 1 |
| Maclouf, J | 1 |
| Tedgui, A | 1 |
1 trial available for pirinixic acid and Coronary Disease
| Article | Year |
|---|---|
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Adult; Apolipoprotein A-II; Apolipoproteins E; Base Sequence; Cells | 1995 |
1 other study available for pirinixic acid and Coronary Disease
| Article | Year |
|---|---|
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
Topics: Acute-Phase Proteins; Animals; Anti-Inflammatory Agents; Aorta; Coronary Disease; COS Cells; Cycloox | 1998 |